Effects of IL-6, JAK, TNF inhibitors and CTLA4-Ig on knee complaints in patients with rheumatoid arthritis
Factors that contribute to the relief of knee complaints From January 2010 to August 2023, a total of 2,321 patients started b/tsDMARD treatment (Fig. 1). Of these, 573 had knee pain and/or swelling at the time of starting b/tsDMARDs (considered baseline). Six months later, 438 individuals returned for follow-up and swelling and/or tender joints were…